Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma

Luciano J. Costa, Yi Lin, R. Frank Cornell, Thomas Martin, Saurabh Chhabra, Saad Z. Usmani, Sundar Jagannath, Natalie S. Callander, Jesus G. Berdeja, Yubin Kang, Ravi Vij, Kelly N. Godby, Ehsan Malek, Amarendra Neppalli, Michaela Liedtke, Mark Fiala, Hong Tian, Satish Valluri, Jennifer Marino, Carolyn C. JacksonArnob Banerjee, Ankit Kansagra, Jordan M. Schecter, Shaji Kumar, Parameswaran Hari

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences